Cargando…
Inhibition of Complement Retards Ankylosing Spondylitis Progression
Ankylosing spondylitis (AS) is a chronic axial spondyloarthritis (SpA) resulting in back pain and progressive spinal ankyloses. Currently, there are no effective therapeutics targeting AS largely due to elusive pathogenesis mechanisms, even as potential candidates such as HLA-B27 autoantigen have be...
Autores principales: | Yang, Chaoqun, Ding, Peipei, Wang, Qingkai, Zhang, Long, Zhang, Xin, Zhao, Jianquan, Xu, Enjie, Wang, Na, Chen, Jianfeng, Yang, Guang, Hu, Weiguo, Zhou, Xuhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048143/ https://www.ncbi.nlm.nih.gov/pubmed/27698377 http://dx.doi.org/10.1038/srep34643 |
Ejemplares similares
-
C5aR1 is a master regulator in Colorectal Tumorigenesis via Immune modulation
por: Ding, Peipei, et al.
Publicado: (2020) -
Ankylosing spondylitis
Publicado: (1980) -
Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010) -
Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976) -
Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)